Form 4: Modular Medical Director and 10% Owner Receives Fully Vested Stock Options

Modular Medical, Inc. Director and 10% Owner, Morgan C. Frank, was granted a total of 9,375 stock options at an exercise price of $0.68 per share, fully vested upon grant.

Summary

• Morgan C. Frank, a Director and 10% Owner of Modular Medical, Inc. (MODD), was granted a total of 9,375 stock options.
• The options were granted in two tranches: 1,875 options and 7,500 options.
• All options have an exercise price of $0.68 per share.
• The options were granted on June 30, 2025, and were fully vested and exercisable on the grant date.
• The options expire on June 30, 2035.
• The grants were made in accordance with the Issuer's Outside Director Compensation Plan.

Sentiment

Score: 7

Explanation: The grant of fully vested stock options to a director and 10% owner is a positive step in aligning management and shareholder interests, reflecting a standard compensation practice. It is a routine transaction and not indicative of significant positive or negative news beyond its direct implications.

Positives

• The options were fully vested and exercisable on the grant date, providing immediate potential for exercise.
• The grant aligns the interests of a key director and 10% owner with those of the shareholders.
• The options were granted under the company's established Outside Director Compensation Plan, indicating a structured approach to director compensation.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing, which is a report of a completed insider transaction.

Management Comments

• The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

Industry Context

Form 4 filings are routine disclosures for insider transactions, such as stock option grants. This filing indicates a standard compensation practice for a director, aligning their incentives with the company's performance and shareholder value, which is common across publicly traded companies.

Comparison to Industry Standards

• Granting stock options to directors is a common practice in the U.S. public company landscape, serving to align director incentives with shareholder value.
• The immediate vesting of options for outside directors is also a common practice, distinguishing them from employee options which often have multi-year vesting schedules.
• The exercise price of $0.68 is typically set at the fair market value of the common stock on the grant date, which is a standard industry practice for compensatory option grants.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for future dilution if options are exercised, but also improved alignment of director interests with shareholder value through equity ownership.
• Employees: No direct impact on employees is mentioned in this filing.

Next Steps

• The reporting person may choose to exercise these options at any time before their expiration date of June 30, 2035.

Key Dates

Keywords

Modular Medical, MODD, stock options, Form 4, insider transaction, director compensation, beneficial ownership, equity grant